100 related articles for article (PubMed ID: 15234532)
1. Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection.
Wei XQ; Niedbala W; Xu D; Luo ZX; Pollock KG; Brewer JM
Immunol Lett; 2004 Jun; 94(1-2):35-7. PubMed ID: 15234532
[TBL] [Abstract][Full Text] [Related]
2. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major.
Dent AL; Doherty TM; Paul WE; Sher A; Staudt LM
J Immunol; 1999 Aug; 163(4):2098-103. PubMed ID: 10438949
[TBL] [Abstract][Full Text] [Related]
3. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice.
Wei XQ; Leung BP; Niedbala W; Piedrafita D; Feng GJ; Sweet M; Dobbie L; Smith AJ; Liew FY
J Immunol; 1999 Sep; 163(5):2821-8. PubMed ID: 10453027
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of disease susceptibility, inflammation and cytokine profile in lmr1/2 congenic mice infected with Leishmania major.
Elso C; Kumar B; Smyth G; Foote S; Handman E
Genes Immun; 2004 May; 5(3):188-96. PubMed ID: 14762398
[TBL] [Abstract][Full Text] [Related]
5. LACK-reactive CD4+ T cells require autocrine IL-2 to mediate susceptibility to Leishmania major.
Gumy A; Aseffa A; Rachinel N; Breton M; Otten L; Tacchini-Cottier F; Röcken M; Doyen N; Acha-Orbea H; Locksley RM; MacDonald HR; Launois P; Louis J
Eur J Immunol; 2006 Jun; 36(6):1465-73. PubMed ID: 16637008
[TBL] [Abstract][Full Text] [Related]
6. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
[TBL] [Abstract][Full Text] [Related]
7. IL-1-induced inflammation promotes development of leishmaniasis in susceptible BALB/c mice.
Voronov E; Dotan S; Gayvoronsky L; White RM; Cohen I; Krelin Y; Benchetrit F; Elkabets M; Huszar M; El-On J; Apte RN
Int Immunol; 2010 Apr; 22(4):245-57. PubMed ID: 20181656
[TBL] [Abstract][Full Text] [Related]
8. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
[TBL] [Abstract][Full Text] [Related]
9. Mast cell degranulation contributes to susceptibility to Leishmania major.
Romão PR; Da Costa Santiago H; Ramos CD; De Oliveira CF; Monteiro MC; De Queiroz Cunha F; Vieira LQ
Parasite Immunol; 2009 Mar; 31(3):140-6. PubMed ID: 19222785
[TBL] [Abstract][Full Text] [Related]
10. IL-18 gene therapy develops Th1-type immune responses in Leishmania major-infected BALB/c mice: is the effect mediated by the CpG signaling TLR9?
Li Y; Ishii K; Hisaeda H; Hamano S; Zhang M; Nakanishi K; Yoshimoto T; Hemmi H; Takeda K; Akira S; Iwakura Y; Himeno K
Gene Ther; 2004 Jun; 11(11):941-8. PubMed ID: 14985787
[TBL] [Abstract][Full Text] [Related]
11. Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection.
Charmoy M; Megnekou R; Allenbach C; Zweifel C; Perez C; Monnat K; Breton M; Ronet C; Launois P; Tacchini-Cottier F
J Leukoc Biol; 2007 Aug; 82(2):288-99. PubMed ID: 17449725
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility to Leishmania major infection in mice: multiple loci and heterogeneity of immunopathological phenotypes.
Lipoldová M; Svobodová M; Krulová M; Havelková H; Badalová J; Nohýnková E; Holán V; Hart AA; Volf P; Demant P
Genes Immun; 2000 Feb; 1(3):200-6. PubMed ID: 11196712
[TBL] [Abstract][Full Text] [Related]
13. T helper differentiation in resistant and susceptible B7-deficient mice infected with Leishmania major.
Brown JA; Greenwald RJ; Scott S; Schweitzer AN; Satoskar AR; Chung C; Schopf LR; van der Woude D; Sypek JP; Sharpe AH
Eur J Immunol; 2002 Jun; 32(6):1764-72. PubMed ID: 12115660
[TBL] [Abstract][Full Text] [Related]
14. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
15. CCL2-independent role of CCR2 in immune responses against Leishmania major.
Quinones MP; Estrada CA; Jimenez F; Martinez H; Willmon O; Kuziel WA; Ahuja SK; Ahuja SS
Parasite Immunol; 2007 Apr; 29(4):211-7. PubMed ID: 17371458
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
Iborra S; Soto M; Carrión J; Alonso C; Requena JM
Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
[TBL] [Abstract][Full Text] [Related]
17. TLR9 signaling is essential for the innate NK cell response in murine cutaneous leishmaniasis.
Liese J; Schleicher U; Bogdan C
Eur J Immunol; 2007 Dec; 37(12):3424-34. PubMed ID: 18034422
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection.
Arinola OG; Louis JS; Tacchini-Cottier F; Aseffa A; Salimonu LS
Afr J Med Med Sci; 2005 Mar; 34(1):65-70. PubMed ID: 15971557
[TBL] [Abstract][Full Text] [Related]
19. Immunological factors governing resistance and susceptibility of mice to Leishmania major infection.
Aguilar-Torrentera F; Carlier Y
Rev Latinoam Microbiol; 2001; 43(3):135-42. PubMed ID: 17061500
[TBL] [Abstract][Full Text] [Related]
20. Resistance to Leishmania major in mice.
Demant P; Lipoldova M; Svobodova M
Science; 1996 Nov; 274(5291):1392-3. PubMed ID: 8966604
[No Abstract] [Full Text] [Related]
[Next] [New Search]